Top ratings in key performance areas reinforce Flatiron’s long-term commitment to community oncology
NEW YORK, NY
Flatiron Health today announced its electronic health record (EHR) OncoEMR®, outperformed all other vendors in 11 out of 20 “key performance indicators” in KLAS’ 2019 Medical Oncology Performance Report, including “Overall Product Quality,” “Ease of Use” and “Overall Satisfaction.”
KLAS, a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider’s voice, observed that “Flatiron Health shows genuine investment in customer success by learning organizations’ unique needs and executing on development plans.”
The KLAS research team interviewed nearly 100 community oncology practices across the U.S. to evaluate their medical oncology vendor in four areas: commitment to customer success, support for workflows that improve patient care, benchmarking and clinical trials functionality and integration with other core EMRs. In the report, a respondent said, “Flatiron is very committed. They continually listen to feedback and make changes based on that feedback. They have changed Flatiron OncoEMR® many times, and each time the system has improved.”
“We’re honored to have performed so well in KLAS’ Medical Oncology Report,” said Nat Turner, co-founder and CEO of Flatiron. “Over the years it’s been a priority of Flatiron to merge clinical and technology talent to create a best-in-class solution that evolves with our customers. We see this as validation that we are on the right track and look forward to continuing to meet the needs of community oncology.”
Flatiron’s software is built to meet the technology needs of the community oncology practice of the future: operationally efficient and prepared to thrive in a world driven by value-based care. For more information about our products and services, click here.
About KLAS
KLAS is a research and insights firm on a global mission to improve healthcare delivery. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services and medical equipment to deliver timely, actionable reports and consulting services. KLAS represents the provider and payer voice and acts as a catalyst for improving vendor performance, highlighting healthcare industry challenges and opportunities, and helping build understanding and consensus for best practices. To learn more about KLAS, go to https://klasresearch.com/home.
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
